Large efforts have been invested to improve in vitro systems with stem cells for toxicity testing (Liu et al. 2017; Godoy et al. 2013 Godoy et al. , 2016 Chen et al. 2017; Cheng et al. 2016; Hammad 2013; Hammad et al. 2017 ). This field of research is of high interest, since it offers the perspective of an unlimited supply of all relevant human cell types that can be applied for in vitro toxicity tests (Leist et al. 2017) . Research efforts have focused particularly on stem cell-derived cardiomyocyte and hepatocyte like cells and on developmental toxicity as well as developmental neurotoxicity (Waldmann et al. 2017; Shinde et al. 2015 Shinde et al. , 2016 Meganathan et al. 2015) . Standardized protocols are available that allow the generation of beating cardiomyocytes derived from embryonic or induced pluripotent stem cells (Sirenko et al. 2017 ). This offers the possibility to study whether test compounds compromise rhythmic beating patterns of the cells (Chaudhari et al. 2017 ). In the field of hepatocyte research, it has become possible to generate hepatocyte-like cells from human embryonic stem cells as well as pluripotent stem cells (Godoy et al. 2015) . These hepatocyte-like cells adopt several features of primary hepatocytes, e.g. secretion of albumin and formation of bile canaliculi. It has, however, become clear that there are also major differences compared to primary hepatocytes. For example, stem cell-derived hepatocyte-like cells adopt unwanted features, such as the expression of colon-specific genes and remaining stemless (Godoy et al. 2015) .
For developmental toxicity testing, stem cells are allowed to differentiate to neuronal precursor cells (Shinde et al. 2015; Colaianna et al. 2017) . Chemicals are added during the differentiation period to test whether this process is disturbed (Pallocca et al. 2016; Rempel et al. 2015) . Such approaches led to the establishment of the developmental toxicity index, which quantifies the fraction of genes involved in normal differentiation whose expression is compromised by the test chemicals (Shinde et al. 2017) . Despite progress in the establishment of reliable in vitro systems and convincing case studies with small numbers of compounds the novel human stem cell-derived test systems have not yet been introduced into toxicological routine. A major limitation is a lack of comprehensive validation studies including sufficient numbers of positive and negative control compounds. It will be interesting to learn with which accuracy the new test systems predict human toxicity.
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